These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34508639)

  • 1. Diagnosis and Outcome of Extranodal Primary Intestinal Lymphoma in Inflammatory Bowel Disease: An ECCO CONFER Case Series.
    Phillips F; Verstockt B; Ribaldone DG; Guerra I; Teich N; Katsanos K; Filip R; Molner T; Karmiris K;
    J Crohns Colitis; 2022 Mar; 16(3):500-505. PubMed ID: 34508639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case Series.
    Barberio B; Savarino E; Verstockt B; Fumery M; Pugliese D; Bertani L; Buda A; Dragoni G; Goren I; Laish I; Spinelli A; Teich N; Truyens M; Ellul P
    J Crohns Colitis; 2022 Dec; 16(12):1845-1852. PubMed ID: 35771951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory Cutaneous Lesions in Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab: An ECCO CONFER Multicentre Case Series.
    Phillips FM; Verstockt B; Sebastian S; Ribaldone D; Vavricka S; Katsanos K; Slattery E; de Suray N; Flores C; Fries W; Vincenzi F; Capoferro E; Bachmann O; Kopylov U
    J Crohns Colitis; 2020 Oct; 14(10):1488-1493. PubMed ID: 32318735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic Thrombocytopaenic Purpura associated with Inflammatory Bowel Disease: a multicentre ECCO CONFER case series.
    Mahajna H; Verstockt B; Bergemalm D; Castiglione F; Rodríguez-Moranta F; Savarino E; Hoentjen F; Bessissow T; Pokryszka J; Cremer A; Eder P; Truyens M; Yerushalmy-Feler A; García MJ; Kopylov U
    J Crohns Colitis; 2023 May; 17(5):722-727. PubMed ID: 36455965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orofacial Granulomatosis Associated with Crohn's Disease: a Multicentre Case Series.
    Phillips F; Verstockt B; Sladek M; de Boer N; Katsanos K; Karmiris K; Albshesh A; Erikson C; Bergemalm D; Molnar T; Ellul P
    J Crohns Colitis; 2022 Mar; 16(3):430-435. PubMed ID: 34498037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune Pancreatitis in Patients with Inflammatory Bowel Disease: A Real-World Multicentre Collaborative ECCO CONFER Study.
    Eder P; Verstock B; Culver E; Dragoni G; Kredel LI; Wypych J; de Paredes AGG; Kaniewska M; Leibovitzh H; Lobaton T; Truyens M; Oracz G; Ribaldone DG; Starzyńska T; Badaoui A; Rahier JF; Bezzio C; Bossuyt P; Falloon K; Pugliese D; Frakes Vozzo C; Jess T; Larsen L; Olesen SS; Pal P; Chaparro M; Dror D; Ellul P; Gromny I; Janiak M; Maciejewska K; Peleg N; Bar-Gil Shitrit A; Szwed Ł; Talar-Wojnarowska R; Snir Y; Weisshof R; Zittan E; Miechowicz I; Goren I
    J Crohns Colitis; 2023 Nov; 17(11):1791-1799. PubMed ID: 37283545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents.
    Karmiris K; Bossuyt P; Sorrentino D; Moreels T; Scarcelli A; Legido J; Dotan I; Naismith GD; Jussila A; Preiss JC; Kruis W; Li AC; Bouguen G; Yanai H; Steinwurz F; Katsanos KH; Subramaniam K; Tarabar D; Zaganas IV; Ben-Horin S;
    J Crohns Colitis; 2015 May; 9(5):382-9. PubMed ID: 25740813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Hypogammaglobulinaemia with Inflammatory Bowel Disease-Like Features: An ECCO CONFER Multicentre Case Series.
    Albshesh A; Eder P; Ribaldone DG; Oldenburg B; de Boer NK; Mantzaris GJ; Savarino EV; Dragoni G; Weisshof R; Truyens M; Festa S; Maillard MH; Capirchio L; Filip R; Theodoraki E; Kopylov U
    J Crohns Colitis; 2022 Jan; 16(1):91-97. PubMed ID: 34274962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoma in Patients with Inflammatory Bowel Disease: A Multicentre Collaborative Study Between GETAID and LYSA.
    Muller M; Broséus J; Guilloteau A; Wasse S; Thiéblemont C; Nancey S; Cadiot G; Amiot A; Laharie D; Vieujean S; Bouhnik Y; Martineau C; Michiels C; Hebuterne X; Savoye G; Franchimont D; Seksik P; Beaugerie L; Maynadié M; Feugier P; Peyrin-Biroulet L
    J Crohns Colitis; 2024 Apr; 18(4):533-539. PubMed ID: 37850555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cogan's Syndrome in Patients With Inflammatory Bowel Disease--A Case Series.
    Vavricka SR; Greuter T; Scharl M; Mantzaris G; Shitrit AB; Filip R; Karmiris K; Thoeringer CK; Boldys H; Wewer AV; Yanai H; Flores C; Schmidt C; Kariv R; Rogler G; Rahier JF;
    J Crohns Colitis; 2015 Oct; 9(10):886-90. PubMed ID: 26188351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014.
    Kirchgesner J; Lemaitre M; Rudnichi A; Racine A; Zureik M; Carbonnel F; Dray-Spira R
    Aliment Pharmacol Ther; 2017 Jan; 45(1):37-49. PubMed ID: 27781286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-hepatic Solid Organ Transplant in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series.
    Ribaldone DG; Vieujean S; Julsgaard M; Armandi A; Zingone F; Savarino E; Cañete F; Aratari A; Imperatore N; Ramos L; Plaza R; Pugliese D; Barberio B; Drobne D; Chaparro M
    J Crohns Colitis; 2023 Jul; 17(7):1097-1102. PubMed ID: 36815684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Risk of Lymphoma in Pediatric Patients Treated for Inflammatory Bowel Disease.
    Egberg MD; Zhang X; Smitherman AB; Kappelman MD
    Am J Gastroenterol; 2023 Feb; 118(2):354-359. PubMed ID: 36219181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
    Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study.
    Kirchgesner J; Nyboe Andersen N; Carrat F; Jess T; Beaugerie L;
    Gut; 2020 May; 69(5):852-858. PubMed ID: 31446428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series.
    Festa S; Zerboni G; Derikx LAAP; Ribaldone DG; Dragoni G; Buskens C; van Dijkum EN; Pugliese D; Panzuto F; Krela-Kaźmierczak I; Mintz HR; Shitrit AB; Chaparro M; Gisbert JP; Kopylov U; Teich N; Vainer E; Nagtegaal I; Hoentjen F; Garcia MJ; Filip R; Foteinogiannopoulou K; Koutroubakis IE; Argollo M; van Wanrooij RLJ; Laja H; Lobaton T; Truyens M; Molnar T; Savarino E; Aratari A; Papi C; Goren I
    J Crohns Colitis; 2022 Jul; 16(6):940-945. PubMed ID: 34864927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease.
    Herrinton LJ; Liu L; Weng X; Lewis JD; Hutfless S; Allison JE
    Am J Gastroenterol; 2011 Dec; 106(12):2146-53. PubMed ID: 22031357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission.
    Wang Y; Wang J; Pekow J; Dalal S; Cohen RD; Ollech J; Israel A; Shogan BD; Micic D; Cannon L; Umanskiy K; Hurst R; Hyman N; Rubin DT; Sakuraba A
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2090-2095. PubMed ID: 31169926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
    Peyrin-Biroulet L; Rahier JF; Kirchgesner J; Abitbol V; Shaji S; Armuzzi A; Karmiris K; Gisbert JP; Bossuyt P; Helwig U; Burisch J; Yanai H; Doherty GA; Magro F; Molnar T; Löwenberg M; Halfvarson J; Zagorowicz E; Rousseau H; Baumann C; Baert F; Beaugerie L;
    Clin Gastroenterol Hepatol; 2023 Mar; 21(3):771-788.e10. PubMed ID: 36152897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.